Skip to content

New Pre-Surgical Scoring System for Uterine Septum

Uterine Septum: Novel Pre-surgical Scoring System to Aid and Standardise Hysteroscopic Metroplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05823103
Enrollment
100
Registered
2023-04-21
Start date
2018-11-18
Completion date
2023-12-30
Last updated
2023-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septate Uterus

Keywords

Hysterscopy, Congenital Uterine Anomaly, Uterine Septum, Septet Uterus, Novel Scoring System, Shawki Septum Scoring System

Brief summary

Comparing surgical outcomes of Hysteroscopic metroplasty for uterine septum when using the standard ESGE or ASRM classifications vs the novel scoring system dubbed Shawki Septum Scoring System. Outcomes based primarily on completion of the septal correction (no residual parts) and avoiding complications, the most significant of which are uterine perforation.

Interventions

DIAGNOSTIC_TESTShawki Septum Scoring System

Utilising the novel scoring system to facilitate feasibility and safety of hysteroscopic metroplasty for uterine septum

DIAGNOSTIC_TESTESHRE ASRM Classification

Utilising the current classification before performing hysteroscopic metroplasty

Sponsors

Ebtesama Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Uterine Septum diagnosed by 3D ultrasound

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with Complete Septum Correction1 monthNo residual septum on 3D ultrasound
Percentage of patients who had an intra-operative Uterine perforationduring the surgeryDiminishing the risk of intra-operative perforation of the fundus

Countries

Egypt

Contacts

Primary ContactYehia Shawki, MRCOG
yehiaoshawki@gmail.com00201001226662

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026